Online prescriptions

Drugs by Letter:

A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
R
S
T
U
V
X
Z

Buy Lamivudine online

Dosage Package Price per pill, $ Price, $
150mgX30 30 2.50 75.00
150mgX60 60 2.00 120.00
Hbv 100mgX30 30 2.90 87.00
Hbv 100mgX60 60 2.32 139.20

Lamivudine Structure

Lamivudine-150 contains 150 mg Lamivudine.
Lamivudine Oral Solution contains 50 mg Lamivudine.

Lamivudine without a prescription

Lamivudine is prescribed to treatment in the class of drugs called Nucleoside Reverse Transcriptase Inhibitors (NRTIs).

Lamivudine is prescribed in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv-1) infection.

Lamivudine Warnings

Before taking Lamivudine, tell your doctor if you have:
- Problems with your muscles;
- Problems with your blood counts;
- Pancreatitis;
- Liver disease;
- Kidney disease;

Lamivudine Side Effects

The possible side effects of Lamivudine are:
- Alone or in combination;
- Fatal cases;
- Have been reported with the use of reverse transcriptase inhibitors;
- Lactic acidosis;
- Severe liver problems;

Contact your doctor immediately if you experience:
- Yellowing of the skin or eyes;
- Weakness in the arms and legs;
- Weakness and tiredness;
- Vomiting;
- Unusual or unexpected stomach discomfort;
- Shortness of breath;
- Pain in the upper stomach area;
- Nausea;

Notify your doctor immediately if you develop symptoms of pancreatitis including:
- Abdominal pain;
- Diarrhea;
- Nausea;
- Vomiting;

Lamivudine Dosage

Pediatric Patients
The recommended oral dose of Lamivudine Oral Solution in HIV-1 infected pediatric patients, 3 months to 16 years of age, is 4 mg/kg twice daily (up to a maximum of 150 mg twice a day), administered in combination with other antiretroviral agents.

Lamivudine is also available as a scored tablet for HIV-1 infected pediatric patients who weigh >14 kg for whom a solid dosage form is appropriate. Before prescribing lamivudine tablets, children should be assessed for the ability to swallow tablets.

No additional dosing of lamivudine is required after routine (4 hour) hemodialysis or peritoneal dialysis.

Although there are insufficient data to recommend a specific dose adjustment of lamivudine in pediatric patients with renal impairment, a reduction in the dose and/or an increase in the dosing interval should be considered.

Adults and Adolescents (>16 years of age)
The recommended oral dose of Lamivudine in HIV-1 infected adults and adolescents >16 years of age is 300 mg daily, administered as either 150 mg twice daily or 300 mg once daily, in combination with other antiretroviral agents.

If lamvir is administered to a patient infected with HIV-1 and HBV, the dosage prescribed for HIV-1 therapy should be used as part of an appropriate combination regimen (see WARNINGS AND PRECAUTIONS ).

Lamivudine Contraindications

Lamivudine is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (eg, anaphylaxis) to any of the components of Lamivudine.